State of Wisconsin Investment Board
ESPR

State of Wisconsin Investment Board’s Esperion Therapeutics ESPR Stock Holding History

State of Wisconsin Investment Board’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$712K Buy
+260,029
New +$823K ﹤0.01% 1836
2023
Q2 		– Sell
-51,830
Closed -$82.4K – 2399
2023
Q1 		$82.4K Sell
51,830
-4,826
-9% -$24.9K ﹤0.01% 2413
2022
Q4 		$353K Buy
56,656
+8,264
+17% +$59.1K ﹤0.01% 2036
2022
Q3 		$324K Sell
48,392
-89,865
-65% -$617K ﹤0.01% 2184
2022
Q2 		$879K Buy
138,257
+31,757
+30% +$180K ﹤0.01% 1717
2022
Q1 		$494K Buy
+106,500
New +$457K ﹤0.01% 1910
2021
Q4 		– Sell
-34,800
Closed -$419K – 2174
2021
Q3 		$419K Hold
34,800
– – ﹤0.01% 1737
2021
Q2 		$736K Hold
34,800
– – ﹤0.01% 1557
2021
Q1 		$976K Sell
34,800
-2,200
-6% -$64.9K ﹤0.01% 1369
2020
Q4 		$962K Sell
37,000
-4,600
-11% -$138K ﹤0.01% 1342
2020
Q3 		$1.55M Buy
41,600
+2,200
+6% +$87.1K ﹤0.01% 1205
2020
Q2 		$2.02M Buy
39,400
+300
+0.8% +$12.6K 0.01% 1121
2020
Q1 		$1.23M Buy
39,100
+1,700
+5% +$89.7K ﹤0.01% 1162
2019
Q4 		$2.23M Hold
37,400
– – 0.01% 1121
2019
Q3 		$1.37M Buy
37,400
+4,900
+15% +$194K ﹤0.01% 1080
2019
Q2 		$1.51M Buy
32,500
+700
+2% +$32.9K ﹤0.01% 1064
2019
Q1 		$1.28M Buy
31,800
+8,400
+36% +$377K ﹤0.01% 1096
2018
Q4 		$1.08M Buy
23,400
+100
+0.4% +$4.82K ﹤0.01% 1106
2018
Q3 		$1.03M Hold
23,300
– – ﹤0.01% 1202
2018
Q2 		$913K Buy
23,300
+6,300
+37% +$318K ﹤0.01% 1197
2018
Q1 		$1.23M Buy
17,000
+6,000
+55% +$441K ﹤0.01% 1064
2017
Q4 		$724K Hold
11,000
– – ﹤0.01% 1213
2017
Q3 		$551K Hold
11,000
– – ﹤0.01% 1268
2017
Q2 		$509K Buy
+11,000
New +$405K ﹤0.01% 1275

Other funds holding ESPR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State of Wisconsin Investment Board's ESPR Position: Q1 2026 in Review

State of Wisconsin Investment Board opened a new position in Esperion Therapeutics (ESPR) in Q1 2026: 260,029 shares worth $712K. The stake represents ﹤0.01% of the portfolio and ranks #1836 among its holdings. This is a return to the name: State of Wisconsin Investment Board previously reported a position in ESPR as recently as Q1 2023.

State of Wisconsin Investment Board first reported a position in ESPR in Q2 2017 and has held it in 24 quarters since. The position peaked at $2.23M in Q4 2019. 206 funds tracked by Wall St. Rank hold ESPR as of Q1 2026.

  • State of Wisconsin Investment Board held 260,029 shares of Esperion Therapeutics worth $712K as of Q1 2026.
  • Esperion Therapeutics was a new State of Wisconsin Investment Board position in Q1 2026.
  • Esperion Therapeutics made up ﹤0.01% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #1836 holding.
  • State of Wisconsin Investment Board first reported a position in Esperion Therapeutics in Q2 2017 and has held it in 24 quarters since.
  • State of Wisconsin Investment Board's Esperion Therapeutics position peaked at $2.23M in Q4 2019.
  • 206 funds tracked by Wall St. Rank held Esperion Therapeutics as of Q1 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.